Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Industry backs biocatalysis for greener manufacturing

Nature Biotechnology volume 31, pages 95–96 (2013)Cite this article

Subjects

Green processing not only has environmental benefits but can also reduce the cost of various stages of manufacture, from preclinical to commercial production. But companies vary in both their willingness and ability to implement these solutions within their organizations. As for those signing up to CHEM21, “Sustainability is very important to these companies,” notes Nick Turner, professor of chemical biology and director of the Centre of Excellence in Biocatalysis at the University of Manchester. Turner leads CHEM21 along with Simon Dolan, director, API Chemistry and Analysis UK at GlaxoSmithKline (London). CHEM21 links a number of academic leaders in green chemistry across Europe with six multinational pharmaceutical companies, all members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) (Table 1). In addition to chemical catalysis and syntheses, the initiative is placing a particular focus on biocatalysis and synthetic biology.

Table 1 CHEM21 participants
Full size table

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. London

    Susan Aldridge

Authors
  1. Susan Aldridge
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Aldridge, S. Industry backs biocatalysis for greener manufacturing. Nat Biotechnol 31, 95–96 (2013). https://doi.org/10.1038/nbt0213-95

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0213-95

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research